BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34549854)

  • 1. Up-front neck dissection followed by chemoradiotherapy for T1-T3 hypopharyngeal cancer with advanced nodal involvement.
    Sato MP; Otsuki N; Kitano M; Ishikawa K; Tanaka K; Kimura T; Doi K
    Head Neck; 2021 Dec; 43(12):3810-3819. PubMed ID: 34549854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The contribution of neck dissection for residual neck disease after chemoradiotherapy in advanced oropharyngeal and hypopharyngeal squamous cell carcinoma patients.
    Suzuki M; Kawakita D; Hanai N; Hirakawa H; Ozawa T; Terada A; Omori K; Hasegawa Y
    Int J Clin Oncol; 2013 Aug; 18(4):578-84. PubMed ID: 22588781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes in N3 Head and Neck Squamous Cell Carcinoma and Role of Upfront Neck Dissection.
    Boros A; Blanchard P; Dade A; Gorphe P; Breuskin I; Even C; Nguyen F; Deutsch E; Bidault F; Janot F; Temam S; Mirghani H; Tao Y
    Laryngoscope; 2021 Mar; 131(3):E846-E850. PubMed ID: 32833260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of advanced hypopharyngeal and laryngeal cancer with and without cartilage invasion.
    Scherl C; Mantsopoulos K; Semrau S; Fietkau R; Kapsreiter M; Koch M; Traxdorf M; Grundtner P; Iro H
    Auris Nasus Larynx; 2017 Jun; 44(3):333-339. PubMed ID: 27569289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neck dissection after chemoradiotherapy for oropharyngeal and hypopharyngeal cancer: the correlation between cervical lymph node metastasis and prognosis.
    Hanai N; Kawakita D; Ozawa T; Hirakawa H; Kodaira T; Hasegawa Y
    Int J Clin Oncol; 2014 Feb; 19(1):30-7. PubMed ID: 23340917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes of induction chemotherapy followed by chemoradiotherapy vs chemoradiotherapy alone as treatment of unresectable head and neck cancer: follow-up of the Spanish Head and Neck Cancer Group (TTCC) 2503 Trial.
    Hitt R; Iglesias L; López-Pousa A; Berrocal-Jaime A; Grau JJ; García-Girón C; Martínez-Trufero J; Guix M; Lambea-Sorrosal J; Del Barco-Morillo E; León-Vintró X; Cunquero-Tomas AJ; Baste N; Ocaña A; Cruz-Hernández JJ;
    Clin Transl Oncol; 2021 Apr; 23(4):764-772. PubMed ID: 32797376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-front neck dissection followed by definitive (chemo)-radiotherapy in head and neck squamous cell carcinoma: Rationale, complications, toxicity rates, and oncological outcomes - A systematic review.
    Elicin O; Nisa L; Dal Pra A; Bojaxhiu B; Caversaccio M; Schmücking M; Aebersold DM; Giger R
    Radiother Oncol; 2016 May; 119(2):185-93. PubMed ID: 26996775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing regional control in p16-negative oropharyngeal cancer: A propensity score-matched analysis of upfront neck dissection and definitive chemoradiotherapy.
    Lee TL; Fang WC; Lee IC; Lirng JF; Chang CF; Hsu YB; Chu PY; Wang YF; Yang MH; Chang PM; Wang LW; Tai SK
    J Chin Med Assoc; 2024 May; 87(5):516-524. PubMed ID: 38501795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction chemotherapy for locally advanced laryngeal and hypopharyngeal cancer: Single institution experience.
    Dagan O; Moore A; Nachalon Y; Alkan U; Biadsee A; Shochat I; Popovtzer A
    Head Neck; 2020 Nov; 42(11):3118-3124. PubMed ID: 32671892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the early detection of esophageal neoplasms in hypopharyngeal cancer patients treated with concurrent chemoradiotherapy.
    Watanabe S; Ogino I; Inayama Y; Sugiura M; Sakuma Y; Kokawa A; Kunisaki C; Inoue T
    Asia Pac J Clin Oncol; 2017 Apr; 13(2):e3-e10. PubMed ID: 25359448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival outcomes for head and neck cancer patients with N3 cervical nodal metastases.
    Virk JS; Ingle M; Podesta CM; Gujral DM; Awad Z
    Clin Otolaryngol; 2020 May; 45(3):342-349. PubMed ID: 31869000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment sequence and survival in locoregionally advanced hypopharyngeal cancer: A surveillance, epidemiology, and end results-based study.
    Hochfelder CG; McGinn AP; Mehta V; Castellucci E; Kabarriti R; Ow TJ
    Laryngoscope; 2020 Nov; 130(11):2611-2621. PubMed ID: 31821572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of the number of metastatic lymph nodes after surgery in locally advanced hypopharyngeal cancer.
    Nishimura A; Yokota T; Hamauchi S; Onozawa Y; Notsu A; Sato F; Kawakami T; Ogawa H; Onoe T; Mukaigawa T
    BMC Cancer; 2022 Oct; 22(1):1101. PubMed ID: 36303119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival outcomes with concurrent chemoradiation for elderly patients with locally advanced head and neck cancer according to the National Cancer Data Base.
    Amini A; Jones BL; McDermott JD; Serracino HS; Jimeno A; Raben D; Ghosh D; Bowles DW; Karam SD
    Cancer; 2016 May; 122(10):1533-43. PubMed ID: 26969811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes following chemoradiotherapy for N3 head and neck squamous cell carcinoma without a planned neck dissection.
    Karakaya E; Yetmen O; Oksuz DC; Dyker KE; Coyle C; Sen M; Prestwich RJ
    Oral Oncol; 2013 Jan; 49(1):55-9. PubMed ID: 22858313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary Surgery vs Chemoradiation Treatment of Advanced-Stage Hypopharyngeal Squamous Cell Carcinoma.
    Harris BN; Biron VL; Donald P; Farwell DG; Luu QC; Bewley AF; Chen AM; Daly ME
    JAMA Otolaryngol Head Neck Surg; 2015 Jul; 141(7):636-40. PubMed ID: 25973578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Planned neck dissection before combined chemoradiation in organ preservation protocol for N2-N3 of supraglottic or hypopharyngeal carcinoma.
    Liu XK; Li Q; Zhang Q; Su Y; Shi YX; Li H; Zeng ZY; Guo ZM
    ORL J Otorhinolaryngol Relat Spec; 2012; 74(2):64-9. PubMed ID: 22327028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival analysis of patients with advanced hypopharyngeal cancer comparing patients who received primary surgery to those who received chemoradiation: An analysis of the NCDB.
    Hochfelder CG; Mehta V; Kabarriti R; McGinn AP; Castellucci E; Ow TJ
    Oral Oncol; 2021 Oct; 121():105470. PubMed ID: 34418696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The management of metastatic neck nodes following induction chemotherapy in N2/3 classification hypopharyngeal carcinoma.
    Li F; Hsueh C; Gong H; Zhu Y; Tao L; Zhou L; Wang S; Zhang M
    Head Neck; 2022 Sep; 44(9):2009-2017. PubMed ID: 35915865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Node-positive hypopharyngeal cancer treated by (chemo)radiotherapy: impact of up-front neck dissection on outcome, toxicity, and quality of life.
    Al-Mamgani A; Meeuwis CA; van Rooij PH; Mehilal R; Basdew H; Sewnaik A; Levendag PC
    Head Neck; 2013 Sep; 35(9):1278-86. PubMed ID: 22907928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.